Diabetic Macular Edema Topic Center

Featured

News

Balancing Medicare Advantage Denials for Patients With Diabetic Macular Edema

03/04/2024

Emry Lloyd

Every year, millions of necessary medical service claims are denied by health care providers; policymakers want to balance these denials for those who need care and how this affects patients with diabetic macular edema.

Every year, millions of...

03/04/2024

First Report Managed Care

News

Subthreshold Micropulse Laser Equivalent to Standard Laser Therapy for DME

01/10/2024

Jolynn Tumolo

Subthreshold micropulse laser therapy was comparable in both efficacy and cost to standard laser therapy in patients with diabetic macular edema (DME) with central retinal thickness less than 400 μm, according to a noninferiority trial...

Subthreshold micropulse laser...

01/10/2024

First Report Managed Care

News

Response to First Anti-VEGF Injection for DME Predicts Long-term Effects of Therapy

11/21/2022

Jolynn Tumolo

To understand whether initial outcomes were a predictor of long-term results, study authors followed patients with diabetic macular edema for several months to assess their responses to anti-vascular endothelial growth factor injections.

To understand whether initial...

11/21/2022

First Report Managed Care

News

Retinal Thickness Lower With Intravitreal Steroids for Diabetic Macular Edema

11/09/2022

Jolynn Tumolo

“Our results reinforce the importance of a continual reevaluation of the role of intravitreal steroids in diabetic macular edema management,” wrote study authors.

“Our results reinforce the...

11/09/2022

First Report Managed Care

News

Treatment More Effective Than Laser Photocoagulation for Improving Diabetic Macular Edema

10/24/2022

Jolynn Tumolo

Findings showed targeted therapy improved visual and anatomical outcomes in patients with diabetic macular edema.

Findings showed targeted therapy...

10/24/2022

First Report Managed Care

News

Anti-VEGF Treatment Changes Aqueous Cytokine Levels in Patients With DME

10/21/2022

Edan Stanley

Researchers examined the alterations of different aqueous humor cytokine concentrations after intravitreal antivascular endothelial growth factor treatment in patients with diabetic macular edema.

Researchers examined the...

10/21/2022

First Report Managed Care

News

Cataract Surgery Outcomes Unaffected by Intravitreal Aflibercept for Diabetic Macular Edema

09/21/2022

Jolynn Tumolo

Intravitreal aflibercept, gender, and other factors "did not interfere with the morphological and functional outcomes of diabetic macular edema in cataract surgery,” researchers said.

Intravitreal aflibercept,...

09/21/2022

First Report Managed Care

News

Intravitreal VEGF Inhibitors Associated With HbA1c Reduction for Patients With DME

09/14/2022

Maria Asimopoulos

Recent findings show the impact of intravitreal aflibercept and ranibizumab on estimated glomerular filtration rates and glycated hemoglobin A1c for patients with diabetic macular edema.

Recent findings show the impact...

09/14/2022

First Report Managed Care

News

Preoperative Bevacizumab Benefits Patients With Diabetes With Vitreous Hemorrhage Without Tractional Detachment

06/02/2022

Jolynn Tumolo

Patients had a lower likelihood of developing diabetic macular edema after receiving preoperative bevacizumab.

Patients had a lower likelihood...

06/02/2022

First Report Managed Care

News

Study Compares 3 Drugs for Diabetic Macular Edema

02/19/2015

A recent study compared 3 drugs for the treatment of diabetic macular edema—bevacizumab, afilbercept, and ranibizumab—to determine which is the most effective treatment for patients with moderate vision loss.

A recent study compared 3 drugs...

02/19/2015

First Report Managed Care

News

FDA Approves Drug for Diabetic Retinopathy with Diabetic Macular Edema

02/09/2015

The FDA approved ranibizumab injection 0.3 mg to treat diabetic retinopathy in patients with diabetic macular edema.

The FDA approved ranibizumab...

02/09/2015

First Report Managed Care

Newsfeed

News

Balancing Medicare Advantage Denials for Patients With Diabetic Macular Edema

03/04/2024

Emry Lloyd

Every year, millions of...

03/04/2024

First Report Managed Care

News

Subthreshold Micropulse Laser Equivalent to Standard Laser Therapy for DME

01/10/2024

Jolynn Tumolo

Subthreshold micropulse laser...

01/10/2024

First Report Managed Care

News

Response to First Anti-VEGF Injection for DME Predicts Long-term Effects of Therapy

11/21/2022

Jolynn Tumolo

To understand whether initial...

11/21/2022

First Report Managed Care

News

Retinal Thickness Lower With Intravitreal Steroids for Diabetic Macular Edema

11/09/2022

Jolynn Tumolo

“Our results reinforce the importance of a continual reevaluation of the role of intravitreal steroids in diabetic macular edema management,” wrote study authors.

“Our results reinforce the...

11/09/2022

First Report Managed Care

News

Treatment More Effective Than Laser Photocoagulation for Improving Diabetic Macular Edema

10/24/2022

Jolynn Tumolo

Findings showed targeted therapy improved visual and anatomical outcomes in patients with diabetic macular edema.

Findings showed targeted therapy...

10/24/2022

First Report Managed Care

News

Anti-VEGF Treatment Changes Aqueous Cytokine Levels in Patients With DME

10/21/2022

Edan Stanley

Researchers examined the alterations of different aqueous humor cytokine concentrations after intravitreal antivascular endothelial growth factor treatment in patients with diabetic macular edema.

Researchers examined the...

10/21/2022

First Report Managed Care

News

Cataract Surgery Outcomes Unaffected by Intravitreal Aflibercept for Diabetic Macular Edema

09/21/2022

Jolynn Tumolo

Intravitreal aflibercept, gender, and other factors "did not interfere with the morphological and functional outcomes of diabetic macular edema in cataract surgery,” researchers said.

Intravitreal aflibercept,...

09/21/2022

First Report Managed Care

News

Intravitreal VEGF Inhibitors Associated With HbA1c Reduction for Patients With DME

09/14/2022

Maria Asimopoulos

Recent findings show the impact of intravitreal aflibercept and ranibizumab on estimated glomerular filtration rates and glycated hemoglobin A1c for patients with diabetic macular edema.

Recent findings show the impact...

09/14/2022

First Report Managed Care

News

Preoperative Bevacizumab Benefits Patients With Diabetes With Vitreous Hemorrhage Without Tractional Detachment

06/02/2022

Jolynn Tumolo

Patients had a lower likelihood of developing diabetic macular edema after receiving preoperative bevacizumab.

Patients had a lower likelihood...

06/02/2022

First Report Managed Care

News

Study Compares 3 Drugs for Diabetic Macular Edema

02/19/2015

A recent study compared 3 drugs...

02/19/2015

First Report Managed Care

News

AHA Voices Concern Over CMS Payment Updates to LTC Hospitals

08/07/2024

Jolynn Tumolo ;

The American Hospital Association (AHA) expressed deep concern in response to long-term care (LTC) hospital payment updates finalized by the Centers for Medicare & Medicaid (CMS) on August 1, 2024.

The American Hospital...

08/07/2024

First Report Managed Care

News

Obesity Linked to Distinct Heart Muscle Abnormalities in Patients With HFpEF, Study Finds

08/05/2024

Lisa Kuhns , PhD, MD;

A recent study published in Nature Cardiovascular Research highlighted the significant impact of severe obesity on myocardial ultrastructure in patients with heart failure with preserved ejection fraction (HFpEF), revealing potential...

A recent study published in...

08/05/2024

First Report Managed Care

News

New Treatment Options Benefit Patients With Relapsed/Refractory Follicular Lymphoma

08/05/2024

Jolynn Tumolo ;

Patients with relapsed/refractory follicular lymphoma tend to have a poorer response and shortened progression-free survival with each subsequent treatment, but new treatment options are emerging.

Patients with...

08/05/2024

First Report Managed Care

Conference Coverage

Centering Patients Within Value-Based Care

07/30/2024

Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.

Asembia 2024 speakers Olivia...

07/30/2024

First Report Managed Care

News

Sun Exposure Linked With Lower Risk of Follicular Lymphoma

07/30/2024

Jolynn Tumolo ;

High sun exposure in warmer months may protect against the development of follicular lymphoma, according to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention.

High sun exposure in warmer...

07/30/2024

First Report Managed Care

News

Updated CDC Recommendation for RSV Vaccination in Older Adults

07/29/2024

Grace Taylor , MS, MA;

The Center for Disease Control and Prevention (CDC) vaccine advisory group updated its recommendation for the use of the respiratory syncytial virus (RSV) vaccine in older adults so that people ages 60 to 74 with certain underlying conditions...

The Center for Disease Control...

07/29/2024

First Report Managed Care

Conference Coverage

Unlocking the Value-Based Care Potential of Health System Specialty Pharmacies

07/26/2024

Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.

Asembia 2024 speaker Bill...

07/26/2024

First Report Managed Care

News

Meta-Analysis Shows Bidirectional Link Between Psoriasis and Asthma

07/26/2024

Jolynn Tumolo ;

A recent systematic review and meta-analysis spanning 12.4 million patients found a significant bidirectional association between psoriasis and asthma. Researchers published their findings online in BMC Pulmonary Medicine.

A recent systematic review and...

07/26/2024

First Report Managed Care

News

HIV Cases Rise Among Gay Latinos

07/24/2024

Grace Taylor , MS, MA;

As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.

As HIV rates continue to rise...

07/24/2024

First Report Managed Care

Conference Coverage

The Impact of AI on Infusion Patient Care and Operational Efficiency

07/22/2024

NICA 2024 session speaker Ashley Joseph of LeanTaas shares insights on how AI technologies are revolutionizing infusion therapy operations, improving care coordination, and ultimately enhancing the patient experience in these critical care...

NICA 2024 session speaker Ashley...

07/22/2024

First Report Managed Care

Diabetic Macular Edema Topic Center

Featured

Newsfeed

Specialties

Events

Year Round Education

HMP Global Products